pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4763 |
Genomic Coordinates | chr22: 46113566 - 46113657 |
Description | Homo sapiens miR-4763 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4763-5p | |||||||||||||||||||||||||||||||||
Sequence | 19| CGCCUGCCCAGCCCUCCUGCU |39 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TRAF1 | ||||||||||||||||||||
Synonyms | EBI6, MGC:10353 | ||||||||||||||||||||
Description | TNF receptor associated factor 1 | ||||||||||||||||||||
Transcript | NM_005658 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TRAF1 | |||||||||||||||||||||
3'UTR of TRAF1 (miRNA target sites are highlighted) |
>TRAF1|NM_005658|3'UTR 1 GGTGGGCGGGGCTCCTGAGGGAGCTCCAACTCAGAAGGGAGCTAGCCAGAGGACTGTGATGCCCTGCCCTTGGCACCCAA 81 GACCTCAGGGCACAAAGATGGGTGAAGGCTGGCATGATCCAAGCAAGACTGAGGGGTCGACTTCGGGCTGGCCATCTGGT 161 TAGGATGGCAGGACGTGGGCTGGGCCCACAAAGGCAAAGGGTCCAGAAGGAGACAGGCAGAGCTGCTCCCCTCTGCACGG 241 ACCATGCGACACTGGGAGGCCAGTGAGCCACTCCGGCCCCGAATGTTGAGGTGGACTCTCACCAAATGAGAAGAAAATGG 321 AACCAGGCTTGGAACCGTAGGACCCAAGCAGAGAAGCTCTCGGGCTAGGAAGATCTCTGCAGGGCCGCCAGGGAGACCTG 401 GACACAGGCCTGCTCTCTTTTTCTCCAGGGTCAGAAACAGGACCGGGTGGAAGGGATGGGGTGCCAGTTTGAATGCAGTC 481 TGTCCAGGCTCGTCATTGGAGGTGAACAAGCAAACCCAGACGGCTCCACTAGGACTTCAAATTGGGGGTTGGATTTGAAG 561 ACTTTTAAGTTTCCTTCCAGCCCAGAAAGTCTCTCATTCTAGGCCTCCTGGCCCAGGTGAGTCCTAGAGCTACAGGGGTT 641 CTGGAAACATTCAGGAGCTTCCTGTCCTCCCAGCTCCTCACTCACCTTCAGTAACCCCCACTGGACTGACCTGGTCCACA 721 GGGCACCTGCCACCCTGGGCCTGGCAGCTCAGCTTCCCCAACACGCAGGAGCACACCCAGCCCCCACATCCTGTGCCTCC 801 ATCAGCTAAACACCACGTCACTTCATGCAGGTGAAACCCAGTCACTGTGAGCTCCCAGGTGCAGCCAGAGGCACCTCAAG 881 AAGAAGAGGGGCATAAACTTTCCTCTTCCTGCCTAGAGGCCCCACCTTTGGTGCTTTCCAGAATCCCGTAACACCTGATT 961 AACTGAGGCATCCACTTCTTTCAGCAGACTGATCAGGACCTCCAAGCCACTGAGCAATGTATAACCCCAAAGAAATAATT 1041 TTTAGAATCTCTTTCGAAGTTTTCCTAAAGTGTATGGTTTGGGAGTTGTTTGTACTGAGCCAGGTTTGAAAAGGCCATTG 1121 CTGAGTTTGAGGTGGTGCCACCAGTTTTGCAGGTGGCATCAGAGGCTGGCATGCTGGCAGGAACATCCCCTCTTAGCCCC 1201 AGTCTTCTCTTTTCTATAATGAGACCCACCCCAGCTTGCCTCCCTCCCTGGCTTCTCTGACCCTCAAAGGAGATGCCACG 1281 CAGGACAGACTGGAGAGAGAAGCCTGGGCAATACTGCCCGCCTGTCATGGCCTGGTGGTGGCCCACACCTATCTTCTCAC 1361 CTTGGAGGCCACACCCAACTTTCCAAAGACCCTGAGACAAGTCAGGACCCTACTACTCTCCCCTGCTGCTTTCCTGACAG 1441 CTTACTCTTCCTCCACCTGCTGAGCCTGTGCCAGACTCCATTGCTCAAATCGTTAGGGTTGCTTCTATAAAAATGGGTCA 1521 GTAGCCCTTCCTGTTCTCTCCAGCCCAGCATACAGGAGGATCAAAGGAGGTGACGGAGCATCGTGGCACGGCAGTCTCAA 1601 TGGGTCAGAAACCCAGGCCAGCTGGGCTCTAAGCCTGGCATCCTGTCATGCTTAGTCCTTCAGCTGAAGATCAGAGGAAG 1681 CCTCTCCCTTGCCCTCTCCAGCTCTAGGGGTTTTCAGGAGGCCCAACTGCAATAATGGAGCACTAGTGCTTTTATGTGCA 1761 ATGGTGTCGTCCATGCACGACAGCAGCAAACATTCTGGGGCTGCTTTTTATTGTTCCCACGGCTGACAGCGTGGCAGCGG 1841 AGACTGTGGAGGCAGTGGAGACTGACTTCTTCCTGCTGACAGCTGGATGTCACACATGAAGGTCTGGCCTAGCGAGTGAT 1921 GGGTCTAGGCCCTGAAACTGATGTCCTAGCAATAACCTCTTGATCCCTACTCACCGAGTGTTGAGCCCAAGGGGGGATTT 2001 GTAGAACAAGCCCCCATGAGAAACAGCTGTTACTCTACACTTTTGATTGCCTATTTCTGATGGCAAGAGATACATACTCT 2081 CTTCAAAGAGCATGAGATGCAGCCATTCTTTCAGCAAAGCTTCATTGACACCTGCACCTGTTAACTGTGTTCGACATTGA 2161 AGGGAGAAAGGCAAGATGTGCACTCTGGACTCAAGAAACTCTTAGTTCAGTGGAGGAAATGAGCAGATAAGTAGATCATT 2241 ATGATTGAGAGTAGGAGAAGCTTAGAGAAAGCACAGAATCCCAGATCCAGCTGGTGAAGGAGGGAAGGCTTCAGGCCTTT 2321 AAGCTCAGCCTGAGAATATTGTGAAATGCAGAGGATGGGGAAAAGGGAAGAGTACCGACTTGAAAACGGAGAGCTGTCTT 2401 GGCTGAGGGCAGGGTCTGTGTGGCAGGATGGGGGAGGGAGTCAGAAGGGTCAGATGAACTGGAGTGTAGACAGCATCAGA 2481 TGCAGCAGTGCCCACCGCCCCCCCCCCCACCCCCCGCCCTGCCCACAGAGCACCTGCTGGTAACCCTGGGCCTATTGAAA 2561 GCAGGATGAGATGATAATTTAAGACACTGAATGATTTCTTTTCCAACAAAGCTCTATGTTAAGTGCA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HeLa |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Chi_124A_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell miR-124 + A
HITS-CLIP data was present in Chi_124B_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell miR-124 + B
HITS-CLIP data was present in Chi_ControlA_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell Control A
HITS-CLIP data was present in Chi_ControlB_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell Control B
... - Chi SW; Zang JB; Mele A; Darnell RB, 2009, Nature. |
Article |
- Chi SW; Zang JB; Mele A; Darnell RB - Nature, 2009
MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 6-8 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.
LinkOut: [PMID: 19536157]
|
CLIP-seq Support 1 for dataset Chi_124A_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell miR-124 + A |
Location of target site | ENST00000373887.3 | 3UTR | GGGGGAGGCAAGAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset Chi_124B_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell miR-124 + B |
Location of target site | ENST00000373887.3 | 3UTR | GGGGGAGGCAAGAUGCAGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset Chi_ControlA_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell Control A |
Location of target site | ENST00000373887.3 | 3UTR | GGGGGAGGCAAGAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset Chi_ControlB_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell Control B |
Location of target site | ENST00000373887.3 | 3UTR | GGGGGAGGCAAGAUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
69 hsa-miR-4763-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT116035 | DEPDC1 | DEP domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT347197 | SIN3B | SIN3 transcription regulator family member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT443248 | C9orf170 | chromosome 9 open reading frame 170 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475164 | IP6K1 | inositol hexakisphosphate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495486 | VTI1B | vesicle transport through interaction with t-SNAREs 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT496755 | TGIF2 | TGFB induced factor homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496863 | C21orf2 | chromosome 21 open reading frame 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499264 | NBPF11 | NBPF member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499517 | MAFK | MAF bZIP transcription factor K | ![]() |
![]() |
2 | 2 | ||||||
MIRT512952 | MKI67 | marker of proliferation Ki-67 | ![]() |
![]() |
2 | 2 | ||||||
MIRT514656 | NUP93 | nucleoporin 93 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517986 | SLC16A13 | solute carrier family 16 member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522816 | KLHL9 | kelch like family member 9 | ![]() |
![]() |
2 | 4 | ||||||
MIRT525495 | CD63 | CD63 molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT528111 | FOXH1 | forkhead box H1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531683 | MYO3A | myosin IIIA | ![]() |
![]() |
2 | 2 | ||||||
MIRT534806 | RAB37 | RAB37, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT573041 | SHMT1 | serine hydroxymethyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576720 | Wars | tryptophanyl-tRNA synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT609727 | MLXIPL | MLX interacting protein like | ![]() |
![]() |
2 | 2 | ||||||
MIRT610843 | FAM180B | family with sequence similarity 180 member B | ![]() |
![]() |
2 | 4 | ||||||
MIRT614735 | STAT5A | signal transducer and activator of transcription 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT616981 | EPOR | erythropoietin receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT617265 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | ![]() |
![]() |
2 | 2 | ||||||
MIRT619405 | INTS7 | integrator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621832 | TIMM8A | translocase of inner mitochondrial membrane 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT621893 | TAF13 | TATA-box binding protein associated factor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630263 | SMIM14 | small integral membrane protein 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634879 | SENP8 | SUMO/sentrin peptidase family member, NEDD8 specific | ![]() |
![]() |
2 | 2 | ||||||
MIRT636863 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | ![]() |
![]() |
2 | 2 | ||||||
MIRT637653 | ADAT1 | adenosine deaminase, tRNA specific 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637699 | ZNF439 | zinc finger protein 439 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637759 | GATAD1 | GATA zinc finger domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638193 | TAOK1 | TAO kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638996 | ADO | 2-aminoethanethiol dioxygenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT642221 | RABAC1 | Rab acceptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643327 | ATCAY | ATCAY, caytaxin | ![]() |
![]() |
2 | 4 | ||||||
MIRT643419 | ERVMER34-1 | endogenous retrovirus group MER34 member 1, envelope | ![]() |
![]() |
2 | 2 | ||||||
MIRT644499 | RNF14 | ring finger protein 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644603 | NT5DC3 | 5'-nucleotidase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644795 | C21orf59 | chromosome 21 open reading frame 59 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648732 | HIST1H2BD | histone cluster 1 H2B family member d | ![]() |
![]() |
2 | 2 | ||||||
MIRT653856 | SHE | Src homology 2 domain containing E | ![]() |
![]() |
2 | 2 | ||||||
MIRT654129 | RPL14 | ribosomal protein L14 | ![]() |
![]() |
2 | 4 | ||||||
MIRT658876 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT671624 | C20orf144 | chromosome 20 open reading frame 144 | ![]() |
![]() |
2 | 4 | ||||||
MIRT677367 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT677579 | TRIM65 | tripartite motif containing 65 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678220 | MACC1 | MACC1, MET transcriptional regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT679613 | RRP36 | ribosomal RNA processing 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686081 | PNPLA3 | patatin like phospholipase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691817 | ICA1L | islet cell autoantigen 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT693869 | COX19 | COX19, cytochrome c oxidase assembly factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT694544 | BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694926 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT697758 | USP37 | ubiquitin specific peptidase 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697891 | UBE2B | ubiquitin conjugating enzyme E2 B | ![]() |
![]() |
2 | 2 | ||||||
MIRT701569 | MYPN | myopalladin | ![]() |
![]() |
2 | 2 | ||||||
MIRT703081 | GPRIN3 | GPRIN family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708104 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708320 | NT5C | 5', 3'-nucleotidase, cytosolic | ![]() |
![]() |
2 | 2 | ||||||
MIRT709878 | TRAF1 | TNF receptor associated factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713545 | GJB1 | gap junction protein beta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716275 | NUP85 | nucleoporin 85 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716621 | CRCP | CGRP receptor component | ![]() |
![]() |
2 | 2 | ||||||
MIRT717987 | C9orf171 | cilia and flagella associated protein 77 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718438 | RAB11B | RAB11B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT722544 | AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724013 | F2RL1 | F2R like trypsin receptor 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|